SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
zzj
Lv1
40 积分
2024-03-25 加入
最近求助
最近应助
互助留言
Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer
9天前
已完结
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design
14天前
已完结
Combining next-generation hormonal therapy with PARP inhibition in metastatic castration-resistant prostate cancer
21天前
已完结
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
21天前
已完结
Combining next-generation hormonal therapy with PARP inhibition in metastatic castration-resistant prostate cancer
21天前
已关闭
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
1个月前
已完结
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma
1个月前
已关闭
Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma
1个月前
已完结
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
1个月前
已完结
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
1个月前
已完结
没有进行任何应助
好的,谢谢
13天前
ok,多谢啦
13天前
好像不全,这个里面只有table1受试者信息,麻烦帮看看还有别的嘛
13天前
无反馈【积分已退回】
21天前
文件是该文章的评论,不是论文原文
21天前
已有材料【积分已退回】
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论